Asia Pacific Markets for Orthopedic Biomaterials 2009

영문목차

Abstract

In 2008, the combined Asia Pacific Biomaterials market was worth $810.2 million. This study of the orthopedic biomaterials markets in Australia, Japan, South Korea and China covers autograft, bone graft substitutes (allograft, DBM and synthetic), hyaluronic acid viscosupplementation, and bone morphogenic growth factor therapy. In each country, the different segments are analyzed by units, procedure numbers and average selling price.

Table of Contents

LIST OF FIGURES

LIST OF CHARTS

EXECUTIVE SUMMARY

• 1.1 TOTAL ASIA PACIFIC ORTHOPEDIC BIOMATERIAL MARKET
• 1.2 ECONOMIC CLIMATE
• 1.3 AUTOGRAFTED BONE PROCEDURES
• 1.4 BONE GRAFT SUBSTITUTE WASTAGE
• 1.5 ALLOGRAFT, DBM AND SYNTHETIC BONE GRAFT SUBSTITUTE MARKETS
• 1.6 HYALURONIC VISCOSUPPLEMENT MARKET
• 1.7 BMP GROWTH FACTOR MARKET
• 1.8 LEADING COMPETITORS

RESEARCH METHODOLOGY

• 2.1 RESEARCH SCOPE
• 2.2 IDATA' S 9-STEP METHODOLOGY
  • Step 1: Project Initiation & Team Selection
  • Step 2: Prepare Data Systems and Perform Secondary Research
  • Step 3: Preparation for Interviews & Survey Design
  • Step 4: Performing Primary Research
  • Step 5: Research Analysis: Establishing Baseline Estimates
  • Step 6: Market Forecasting
  • Step 7: Identify Strategic Opportunities
  • Step 8: Final Review and Market Release
  • Step 9: Customer Feedback and Market Monitoring

OVERVIEW OF ASIA PACIFIC ORTHOPEDIC BIOMATERIALS

• 3.1 INTRODUCTION
• 3.2 OVERVIEW
  • 3.2.1 Growth Factors
  • 3.2.2 Bone Graft Substitutes
  • 3.2.3 Hyaluronic Acid Viscosupplementation
• 3.3 CURRENCY EXCHANGE RATE
• 3.4 MARKET ANALYSIS AND FORECAST
  • 3.4.1 Analysis and Forecast of Total Market
• 3.5 MARKET DRIVERS
• 3.6 MARKET LIMITERS
• 3.7 COMPETITIVE ANALYSIS
  • 3.7.1 Leading Competitors
  • 3.7.2 Market Concentration
• 3.8 MERGERS AND ACQUISITIONS

COUNTRY PROFILES

• 4.1 INTRODUCTION
  • 4.1.1 Population
  • 4.1.2 GDP per Capita
  • 4.1.3 Procedures
  • 4.1.4 Price Index
• 4.2 AUSTRALIA
• 4.3 JAPAN.
• 4.4 KOREA
• 4.5 CHINA

BONE GRAFT SUBSTITUTE MARKET

• 5.1 TOTAL MARKET
  • 5.1.1 Introduction
  • 5.1.2 Overview
  • 5.1.3 Volume Usage and Pricing
    • 5.1.3.1 Wastage
    • 5.1.3.2 Volumes Represented per Procedure
  • 5.1.4 Autograft Procedures
  • 5.1.5 Spine Fusion Procedures
  • 5.1.6 Market Analysis and Forecast
    • 5.1.6.1 Total Commercial Bone Graft Substitute Market
    • 5.1.6.2 Total Utilized Bone Graft Substitute Market
• 5.2 AUSTRALIA
  • 5.2.1 Autograft Procedures
  • 5.2.2 Spine Fusion Procedures
  • 5.2.3 Market Forecast and Analysis
    • 5.2.3.1 Total Commercial Bone Graft Substitute Market
    • 5.2.3.2 Total Utilized Bone Graft Substitute Market
    • 5.2.3.3 Total Market by Allograft, DBM and Synthetic Materials
    • 5.2.3.4 Total Spine Market by Allograft and Synthetic Materials
    • 5.2.3.5 Cervical Spine Market by Allograft and Synthetic Materials
    • 5.2.3.6 Thoracolumbar Spine Market by Allograft and Synthetic Materials
    • 5.2.3.7 Extremity Market by Allograft and Synthetic Materials
    • 5.2.3.8 Craniomaxillofacial Market by Allograft and Synthetic Materials
  • 5.2.4 Market Drivers and Limiters
    • 5.2.4.1 Market Drivers
    • 5.2.4.2 Market Limiters
  • 5.2.5 Competitive Analysis
• 5.3 JAPAN
  • 5.3.1 Autograft Procedures
  • 5.3.2 Spine Fusion Procedures
  • 5.3.3 Market Forecast and Analysis
    • 5.3.3.1 Total Commercial Bone Graft Substitute Market
    • 5.3.3.2 Total Utilized Bone Graft Substitute Market
    • 5.3.3.3 Total Market by Allograft and Synthetic Materials
    • 5.3.3.4 Total Spine Market Synthetic Materials
    • 5.3.3.5 Cervical Spine Market by Synthetic Materials
    • 5.3.3.6 Thoracolumbar Spine Market by Synthetic Materials
    • 5.3.3.7 Extremity Market by Synthetic Materials
    • 5.3.3.8 Craniomaxillofacial Market by Synthetic Materials
  • 5.3.4 Market Drivers and Limiters
    • 5.3.4.1 Market Drivers
    • 5.3.4.2 Market Limiters
  • 5.3.5 Competitive Analysis
• 5.4 KOREA
  • 5.4.1 Autograft Procedures
  • 5.4.2 Spine Fusion Procedures
  • 5.4.3 Market Forecast and Analysis
    • 5.4.3.1 Total Commercial Bone Graft Substitute Market
    • 5.4.3.2 Total Utilized Bone Graft Substitute Market
    • 5.4.3.3 Total Market by Allograft, DBM and Synthetic Materials
    • 5.4.3.4 Total Spine Market by Synthetic Materials
    • 5.4.3.5 Cervical Spine by Synthetic Materials
    • 5.4.3.6 Thoracolumbar Spine Market by Synthetic Materials
    • 5.4.3.7 Extremity Market by Synthetic Materials
    • 5.4.3.8 Craniomaxillofacial Market by Synthetic Materials
  • 5.4.4 Market Drivers and Limiters
    • 5.4.4.1 Market Drivers
    • 5.4.4.2 Market Limiters
  • 5.4.5 Competitive Analysis
• 5.5 CHINA
  • 5.5.1 Autograft Procedures
  • 5.5.2 Spine Fusion Procedures
  • 5.5.3 Market Forecast and Analysis
    • 5.5.3.1 Total Commercial Bone Graft Substitute Market
    • 5.5.3.2 Total Utilized Bone Graft Substitute Market
    • 5.5.3.3 Total Market by Allograft and Synthetic Materials
    • 5.5.3.4 Total Spine Market by Synthetic Materials
    • 5.5.3.5 Cervical Spine Market by Synthetic Materials
    • 5.5.3.6 Thoracolumbar Spine Market by Synthetic Materials
    • 5.5.3.7 Extremity Market by Synthetic Materials
    • 5.5.3.8 Craniomaxillofacial Market by Synthetic Materials
  • 5.5.4 Market Drivers and Limiters
    • 5.5.4.1 Market Drivers
    • 5.5.4.2 Market Limiters
  • 5.5.5 Competitive Analysis

BMP GROWTH FACTOR MARKET

• 6.1 INTRODUCTION
  • 6.1.1 Overview
  • 6.1.2 Potential Complications
  • 6.1.3 Future Indications
• 6.2 MARKET ANALYSIS AND FORECAST
  • 6.2.1 Total Growth Factor Market
  • 6.2.2 Australian Growth Factor Market
  • 6.2.3 Korean Growth Factor Market
• 6.3 MARKET DRIVERS AND LIMITERS
  • 6.3.1.1 Market Drivers
  • 6.3.1.2 Market Limiters
• 6.4 COMPETITIVE ANALYSIS

HYALURONIC ACID VISCOSUPPLEMENTATION MARKET

• 7.1 INTRODUCTION
  • 7.1.1 Three-Injection Cycle Products
  • 7.1.2 Five-Injection Cycle Products
  • 7.1.3 Single-Injection Cycle Products
• 7.2 TOTAL ASIA PACIFIC HYALURONIC ACID MARKET
  • 7.2.1 Market Forecast and Analysis
• 7.3 AUSTRALIAN HYALURONIC ACID MARKET
  • 7.3.1 Market Forecast and Analysis
  • 7.3.2 Market Drivers and Limiters
    • 7.3.2.1 Market Drivers
    • 7.3.2.2 Market Limiters
  • 7.3.3 Competitive Analysis
• 7.4 JAPANESE HYALURONIC ACID MARKET
  • 7.4.1 Market Forecast and Analysis
  • 7.4.2 Market Drivers and Limiters
    • 7.4.2.1 Market Drivers
    • 7.4.2.2 Market Limiters
  • 7.4.3 Competitive Analysis
• 7.5 KOREAN HYALURONIC ACID MARKET
  • 7.5.1 Market Forecast and Analysis
  • 7.5.2 Market Drivers and Limiters
    • 7.5.2.1 Market Drivers
    • 7.5.2.2 Market Limiters
  • 7.5.3 Competitive Analysis
• 7.6 CHINESE HYALURONIC ACID MARKET
  • 7.6.1 Market Forecast and Analysis
  • 7.6.2 Market Drivers and Limiters
    • 7.6.2.1 Market Drivers
    • 7.6.2.2 Market Limiters
  • 7.6.3 Competitive Analysis

ABBREVIATIONS

APPENDIX 1: TAIWANESE SPINAL FUSION PROCEDURES

APPENDIX 2: TAIWANESE HYALURONIC ACID VISCOSUPPLEMENTATION

• MARKET

LIST OF FIGURES

EXECUTIVE SUMMARY

RESEARCH METHODOLOGY

OVERVIEW OF ASIA PACIFIC ORTHOPEDIC BIOMATERIALS

• Figure 3-1: Exchange Rate Between Euro and Other Currencies, 2008
• Figure 3-2: Total Orthopedic Biomaterial Market, Asia Pacific, 2005 - 2015 (US$)
• Figure 3-3: Market Drivers, Orthopedic Biomaterials Market, Asia Pacific, 2008
• Figure 3-4: Market Limiters, Orthopedic Biomaterials Market, Asia Pacific, 200827
• Figure 3-5: Leading Competitors, Orthopedic Biomaterials Market, Asia Pacific, 2008
• Figure 3-6 Market Concentration, Orthopedic Biomaterials Market, U.S., 2007

COUNTRY PROFILES

BONE GRAFT SUBSTITUTE MARKET

• Figure 5-1: Total Autograft Procedures, Asia Pacific, 2005 - 2015
• Figure 5-2: Spine Fusion Procedures, Asia Pacific, 2005 - 2015
• Figure 5-3: Total Bone Graft Substitute Market, Asia Pacific, 2005 - 2015 (US$)
• Figure 5-4: Total Procedures by Indication, Asia Pacific, 2005 - 2015
• Figure 5-5: Total Utilized Market Value by Indication, Asia Pacific, 2005 - 2015 (US$)
• Figure 5-6: Utilized Bone Graft Substitute Market, Asia Pacific, 2005 - 2015 (U$)
• Figure 5-7: Total Autograft Procedures, Australia, 2005 - 2015
• Figure 5-8: Spine Fusion Procedures, Australia, 2005 - 2015
• Figure 5-9: Total Bone Graft Substitute Market, Australia, 2005 - 2015 (US$)
• Figure 5-10: Total Bone Graft Substitute Market, Australia, 2005 - 2015 (AU$M)
• Figure 5-11: Total Procedures by Indication, Australia, 2005 - 2015
• Figure 5-12: Total Utilized Market Value by Indication, Australia, 2005 - 2015 (US$)
• Figure 5-13: Total Utilized Market Value by Indication, Australia, 2005 - 2015 (AU$)
• Figure 5-14: Utilized Bone Graft Substitute Market, Australia, 2005 - 2015 (US$)
• Figure 5-15: Utilized Bone Graft Substitute Market, Australia, 2005 - 2015 (US$)
• Figure 5-16: Total Allograft Market, Australia, 2005 - 2015 (US$)
• Figure 5-17: Total Allograft Market, Australia, 2005 - 2015 (AU$)
• Figure 5-18: Total DBM Market, Australia, 2005 - 2015 (US$)
• Figure 5-19: Total DBM Market, Australia, 2005 - 2015 (AU$)
• Figure 5-20: Total Synthetic Market, Australia, 2005 - 2015 (US$)
• Figure 5-21: Total Synthetic Market, Australia, 2005 - 2015 (AU$)
• Figure 5-22: Allograft Spine Market, Australia, 2005 - 2015 (US$)
• Figure 5-23: Allograft Spine Market, Australia, 2005 - 2015 (AU$)
• Figure 5-24: Synthetic Spine Market, Australia, 2005 - 2015 (US$)
• Figure 5-25: Synthetic Spine Market, Australia, 2005 - 2015 (AU$)
• Figure 5-26: Allograft Cervical Spine Market, Australia, 2005 - 2015 (US$)
• Figure 5-27: Allograft Cervical Spine Market, Australia, 2005 - 2015 (AU$)
• Figure 5-28: Synthetic Cervical Spine Market, Australia, 2005 - 2015 (US$)
• Figure 5-29: Synthetic Cervical Spine Market, Australia, 2005 - 2015 (AU$)
• Figure 5-30: Allograft Thoracolumbar Spine Market, Australia, 2005 - 2015 (US$)
• Figure 5-31: Allograft Thoracolumbar Spine Market, Australia, 2005 - 2015 (AU$)
• Figure 5-32: Synthetic Thoracolumbar Spine Market, Australia, 2005 - 2015 (US$)
• Figure 5-33: Synthetic Thoracolumbar Spine Market, Australia, 2005 - 2015 (AU$)
• Figure 5-34: Allograft Extremity Market, Australia, 2005 - 2015 (US$)
• Figure 5-35: Allograft Extremity Market, Australia, 2005 - 2015 (AU$)
• Figure 5-36: Synthetic Extremity Market, Australia, 2005 - 2015 (US$)
• Figure 5-37: Synthetic Extremity Market, Australia, 2005 - 2015 (AU$)
• Figure 5-38: Allograft CMF Market, Australia, 2005 - 2015 (US$)
• Figure 5-39: Allograft CMF Market, Australia, 2005 - 2015 (AU$)
• Figure 5-40: Synthetic CMF Market, Australia, 2005 - 2015 (US$)
• Figure 5-41: Synthetic CMF Market, Australia, 2005 - 2015 (AU$)
• Figure 5-42: Market Drivers and Limiters, Australia, Bone Graft Substitute Market, 2005 - 2015
• Figure 5-43: Leading Competitors, Bone Graft Substitute Market, Australia, 200875
• Figure 5-44: Total Autograft Procedures, Japan, 2005 - 2015
• Figure 5-45: Spine Fusion Procedures, Japan, 2005 - 2015
• Figure 5-46: Total Bone Graft Substitute Market, Japan, 2005 - 2015 (US$)
• Figure 5-47: Total Bone Graft Substitute Market, Japan, 2005 - 2015 (JP¥)
• Figure 5-48: Total Procedures by Indication, Japan, 2005 - 2015
• Figure 5-49: Total Utilized Market Value by Indication, Japan, 2005 - 2015 (US$)
• Figure 5-50: Total Utilized Market Value by Indication, Japan, 2005 - 2015 (JP¥M)
• Figure 5-51: Utilized Bone Graft Substitute Market, Japan, 2005 - 2015 (US$)
• Figure 5-52: Utilized Bone Graft Substitute Market, Japan, 2005 - 2015 (JP¥)
• Figure 5-53: Total Allograft Market, Japan, 2005 - 2015 (US$)
• Figure 5-54: Total Allograft Market, Japan, 2005 - 2015 (JP¥)
• Figure 5-55: Total Synthetic Market, Japan, 2005 - 2015 (US$)
• Figure 5-56: Total Synthetic Market, Japan, 2005 - 2015 (JP¥)
• Figure 5-57: Synthetic Spine Market, Japan, 2005 - 2015 (US$)
• Figure 5-58: Synthetic Spine Market, Japan, 2005 - 2015 (JP¥)
• Figure 5-59: Synthetic Cervical Spine Market, Japan, 2005 - 2015 (US$)
• Figure 5-60: Synthetic Cervical Spine Market, Japan, 2005 - 2015 (JP¥)
• Figure 5-61: Synthetic Thoracolumbar Spine Market, Japan, 2005 - 2015 (US$)
• Figure 5-62: Synthetic Thoracolumbar Spine Market, Japan, 2005 - 2015 (JP¥)
• Figure 5-63: Synthetic Extremity Market, Japan, 2005 - 2015 (US$)
• Figure 5-64: Synthetic Extremity Market, Japan, 2005 - 2015 (JP¥)
• Figure 5-65: Synthetic CMF Market, Japan, 2005 - 2015 (US$)
• Figure 5-66: Synthetic CMF Market, Japan, 2005 - 2015 (JP¥)
• Figure 5-67: Market Drivers and Limiters, Japan, Bone Graft Substitute Market, 2005 - 2015
• Figure 5-68: Leading Competitors, Bone Graft Substitute Market, Japan, 2008
• Figure 5-69: Total Autograft Procedures, Korea, 2005 - 2015
• Figure 5-70: Spine Fusion Procedures, Korea, 2005 - 2015
• Figure 5-71: Total Bone Graft Substitute Market, Korea, 2005 - 2015 (US$)
• Figure 5-72: Total Bone Graft Substitute Market, Korea, 2005 - 2015 (KRW M)
• Figure 5-73: Total Procedures by Indication, Korea, 2005 - 2015
• Figure 5-74: Total Utilized Market Value, Korea, 2005 - 2015 (US$)
• Figure 5-75: Total Utilized Market Value, Korea, 2005 - 2015 (KRW M)
• Figure 5-76: Utilized Bone Graft Substitute Market, Korea, 2005 - 2015 (US$)
• Figure 5-77: Utilized Bone Graft Substitute Market, Korea, 2005 - 2015 (KRW M)
• Figure 5-78: Total Allograft Market, Korea, 2005 - 2015 (US$)
• Figure 5-79: Total Allograft Market, Korea, 2005 - 2015 (KRW M)
• Figure 5-80: Total DBM Market, Korea, 2005 - 2015 (US$)
• Figure 5-81: Total DBM Market, Korea, 2005 - 2015 (KRW M)
• Figure 5-82: Total Synthetic Market, Korea, 2005 - 2015 (US$)
• Figure 5-83: Total Synthetic Market, Korea, 2005 - 2015 (US$)
• Figure 5-84: Synthetic Spine Market, Korea, 2005 - 2015 (US$)
• Figure 5-85: Synthetic Spine Market, Korea, 2005 - 2015 (US$)
• Figure 5-86: Synthetic Cervical Spine Market, Korea, 2005 - 2015 (US$)
• Figure 5-87: Synthetic Cervical Spine Market, Korea, 2005 - 2015 (KRW M)
• Figure 5-88: Synthetic Thoracolumbar Spine Market, Korea, 2005 - 2015 (US$)
• Figure 5-89: Synthetic Thoracolumbar Spine Market, Korea, 2005 - 2015 (KRW M)
• Figure 5-90: Synthetic Extremity Market, Korea, 2005 - 2015 (US$)
• Figure 5-91: Synthetic Extremity Market, Korea, 2005 - 2015 (KRW M)
• Figure 5-92: Synthetic CMF Market, Korea, 2005 - 2015 (US$)
• Figure 5-93: Synthetic CMF Market, Korea, 2005 - 2015 (KRW M)
• Figure 5-94: Market Drivers and Limiters, Korea, Bone Graft Substitute Market, 2005 - 2015
• Figure 5-95: Leading Competitors, Bone Graft Substitute Market, Australia, 2008116
• Figure 5-96: Total Autograft Procedures, China, 2005 - 2015
• Figure 5-97: Spine Fusion Procedures, China, 2005 - 2015
• Figure 5-98: Total Bone Graft Substitute Market, China, 2005 - 2015 (US$)
• Figure 5-99: Total Bone Graft Substitute Market, China, 2005 - 2015 ((CN¥)
• Figure 5-100: Total Procedures by Indication, China, 2005 - 2015
• Figure 5-101: Total Utilized Market Value by Indication, China, 2005 - 2015 (US$)
• Figure 5-102: Total Utilized Market Value by Indication, China, 2005 - 2015 (CN¥M)
• Figure 5-103: Utilized Bone Graft Substitute Market, China, 2005 - 2015 (US$)
• Figure 5-104: Utilized Bone Graft Substitute Market, China, 2005 - 2015 (CN¥M)
• Figure 5-105: Total Allograft Market, China, 2005 - 2015 (US$)
• Figure 5-106: Total Allograft Market, China, 2005 - 2015 (CN¥M)
• Figure 5-107: Total Synthetic Market, China, 2005 - 2015 (US$)
• Figure 5-108: Total Synthetic Market, China, 2005 - 2015 (CN¥M)
• Figure 5-109: Synthetic Spine Market, China, 2005 - 2015 (US$)
• Figure 5-110: Synthetic Spine Market, China, 2005 - 2015 (CN¥)
• Figure 5-111: Synthetic Cervical Spine Market, China, 2005 - 2015 (US$)
• Figure 5-112: Synthetic Cervical Spine Market, China, 2005 - 2015 (CN¥M)
• Figure 5-113: Synthetic Thoracolumbar Spine Market, China, 2005 - 2015 (US$)
• Figure 5-114: Synthetic Thoracolumbar Spine Market, China, 2005 - 2015 (CN¥)
• Figure 5-115: Synthetic Extremity Market, China, 2005 - 2015 (US$)
• Figure 5-116: Synthetic Extremity Market, China, 2005 - 2015 (CN¥M)
• Figure 5-117: Synthetic CMF Market, China, 2005 - 2015 (US$)
• Figure 5-118: Synthetic CMF Market, China, 2005 - 2015 (CN¥M)
• Figure 5-119: Market Drivers and Limiters, China, Bone Graft Substitute Market, 2005 - 2015

BMP GROWTH FACTOR MARKET

• Figure 6-1: Orthopedic Growth Factor Market, Asia Pacific, 2005 - 2015 (US$)
• Figure 6-2: Orthopedic Growth Factor Market, Australia, 2005 - 2015 (US$)
• Figure 6-3: Orthopedic Growth Factor Market, Australia, 2005 - 2015 ($US)
• Figure 6-4: Orthopedic Growth Factor Market, Korea, 2005 - 2015 (US$)
• Figure 6-5: Orthopedic Growth Factor Market, Korea, 2005 - 2015 ($US)
• Figure 6-6: Drivers and Limiters, Orthopedic Growth Factor Market, Korea, 2005 - 2015
• Figure 6-7: Leading Competitors, Orthopedic Growth Factor Market, Asia
• Pacific, 2008

HYALURONIC ACID VISCOSUPPLEMENTATION MARKET

• Figure 7-1: Total Hyaluronic Acid Viscosupplementation Market, Asia Pacific, 2005 - 2015 (US$)
• Figure 7-2: Total Hyaluronic Acid Viscosupplementation Market, Australia, 2005 - 2015 (US$)
• Figure 7-3: Total Hyaluronic Acid Viscosupplementation Market, Australia, 2005 - 2015 ($US)
• Figure 7-4: Drivers and Limiters, Hyaluronic Acid Viscosupplement Market, Australia, 2008
• Figure 7-5: Leading Competitors, Hyaluronic Acid Viscosupplementation Market, Australia, 2008
• Figure 7-6: Total Hyaluronic Acid Viscosupplementation Market, Japan, 2005 - 2015 (US$)
• Figure 7-7: Total Hyaluronic Acid Viscosupplementation Market, Japan, 2005 - 2015 ($US)
• Figure 7-8: Drivers and Limiters, Hyaluronic Acid Viscosupplement Market, Japan, 2008
• Figure 7-9: Leading Competitors, Hyaluronic Acid Viscosupplementation Market, Japan, 2008
• Figure 7-10: Total Hyaluronic Acid Viscosupplementation Market, Korea, 2005 - 2015 (US$)
• Figure 7-11: Total Hyaluronic Acid Viscosupplementation Market, Korea, 2005 - 2015 ($US)
• Figure 7-12: Drivers and Limiters, Hyaluronic Acid Viscosupplement Market, Korea, 2008
• Figure 7-13: Leading Competitors, Hyaluronic Acid Viscosupplementation Market, Korea, 2008
• Figure 7-14: Total Hyaluronic Acid Viscosupplementation Market, China, 2005 - 2015 (US$)
• Figure 7-15: Total Hyaluronic Acid Viscosupplementation Market, China, 2005 - 2015 ($US)
• Figure 7-16: Drivers and Limiters, Hyaluronic Acid Viscosupplement Market, China, 2008
• Figure 7-17: Leading Competitors, Hyaluronic Acid Viscosupplementation Market, China, 2008

ABBREVIATIONS

APPENDIX 1: TAIWANESE SPINAL FUSION PROCEDURES

• Figure 9-1: Spine Fusion Procedures, Taiwan, 2005 - 2015

APPENDIX 2: TAIWANESE HYALURONIC ACID VISCOSUPPLEMENTATION MARKET

• Figure 10-1 Hyaluronic Acid Viscosupplement Market, Taiwan, 2005 - 2015 (US$)
• Figure 10-2 Hyaluronic Acid Viscosupplement Market, Taiwan, 2005 - 2015 (NT$)

LIST OF CHART S

EXECUTIVE SUMMARY

• Chart 1-1: Total Biomaterial Market, Asia Pacific, 2005 - 2015 (US$)
• Chart 1-2: Unit and Average Selling Prices, Bone Graft Substitute Market, Asia Pacific, 2005 - 2008
• Chart 1-3: Autograft Procedures, Asia Pacific, 2008
• Chart 1-4: BGS Units, Used and Unused, Asia Pacific, 2005 - 2015
• Chart 1-5: Units Implanted, Bone Graft Substitute Market, Asia Pacific, 2008
• Chart 1-6: Hyaluronic Viscosupplementation Procedures, Korea, 2008
• Chart 1-7: BMP Growth Factor Market, Asia Pacific, 2005 - 2015
• Chart 1-8: Leading Competitors, Orthopedic Biomaterial Market, Asia Pacific, 2008

RESEARCH METHODOLOGY

OVERVIEW OF ASIA PACIFIC ORTHOPEDIC BIOMATERIALS

• Chart 3-1: Total Orthopedic Biomaterial Market, Asia Pacific, 2005 - 2015 (US$)
• Chart 3-2: Total Orthopedic Biomaterial Market by Segment, Asia Pacific, 2008
• Chart 3-3: Leading Competitors, Orthopedic Biomaterials Market, Asia Pacific, 2008

COUNTRY PROFILES

• Chart 4-1: Australian Price Index, GDP per Capita, and Population, 2008
• Chart 4-2: Japanese Price Index, GDP per Capita, and Population, 2008
• Chart 4-3: Korea Price Index, GDP per Capita, and Population, 2008
• Chart 4-4: Chinese Price Index, GDP per Capita, and Population, 2008
• Chart 4-5: Bone Graft Substitute Procedures per Population, Asia Pacific, 2008

BONE GRAFT SUBSTITUTE MARKET

• Chart 5-1: Total Bone Graft Substitute Market, Asia Pacific, 2005 - 2015 (US$)
• Chart 5-2: Total Bone Graft Substitute Market, Australia, 2005 - 2015 (US$)
• Chart 5-3: Total Bone Graft Substitute Market, Japan, 2005 - 2015 (US$)
• Chart 5-4: Total Bone Graft Substitute Market, Korea, 2005 - 2015 (US$)
• Chart 5-5: Total Bone Graft Substitute Market, China, 2005 - 2015 (US$)

BMP GROWTH FACTOR MARKET

• Chart 6-1: Orthopedic Growth Factor Market, Asia Pacific, 2005 - 2015 (US$)
• Chart 6-2: Orthopedic Growth Factor Market, Australia, 2005 - 2015 (US$)
• Chart 6-3: Orthopedic Growth Factor Market, Korea, 2005 - 2015 (US$)
• Chart 6-4: Leading Competitors, Orthopedic Growth Factor Market, Asia Pacific, 2008

HYALURONIC ACID VISCOSUPPLEMENTATION MARKET

• Chart 7-1: Total Hyaluronic Acid Viscosupplement Market, Asia Pacific, 2005 2015 (US$)
• Chart 7-2: Total Hyaluronic Acid Viscosupplement Market, Australia, 2005 2015 (US$)
• Chart 7-3: Leading Competitors, Hyaluronic Acid Viscosupplementation Market, Australia, 2008
• Chart 7-4: Total Hyaluronic Acid Viscosupplement Market, Japan, 2005 - 2015 (US$)
• Chart 7-5: Leading Competitors, Hyaluronic Acid Viscosupplementation Market, Japan, 2008
• Chart 7-6: Total Hyaluronic Acid Viscosupplement Market, Korea, 2005 - 2015162
• Chart 7-7: Leading Competitors, Hyaluronic Acid Viscosupplementation Market, Korea, 2008
• Chart 7-8: Total Hyaluronic Acid Viscosupplement Market, China, 2005 - 2015

ABBREVIATIONS

APPENDIX 1: TAIWANESE SPINAL FUSION PROCEDURES

APPENDIX 2: TAIWANESE HYALURONIC ACID VISCOSUPPLEMENTATION MARKET

• Chart 10-1: Hyaluronic Acid Viscosupplement Market, Taiwan, 2005 - 2015 (US$)

관련자료

바이오매트리얼 관련 보고서

미국의 정형외과용 바이오소재 시장(2012년)

U.S. Market for Orthopedic Biomaterials 2012

가격: USD 6,995

출판일: 2012년 05월

구강관리 제품 및 치과용 소모품 시장(치과용 바이오소재, 전문용품 및 수복제) : 현재 동향, 시장 기회, 세계 시장 예측(∼2016년)

Oral Care Products & Other Dental Consumables Market (Dental Biomaterials, Specialty Products, & Restoratives) Current Trends, Opportunities & Global Forecasts to 2016

가격: USD 4,650

출판일: 2012년 04월

유럽의 치과용 골이식 대체물, 재생막 및 조직공학 제품 시장(21개국) : 2012년

European Markets for Dental Bone Graft Substitutes, Dental Membranes and Tissue Engineering 2012 (21 countries)

가격: USD 10,995

출판일: 2012년 03월

iData Research Inc.사의 바이오테크놀러지관련 보고서

유럽의 정형외과 연조직 및 스포츠 의학 시장(2012년)

European Markets for Orthopedic Soft Tissue & Sports Medicine 2012

가격: USD 10,995

출판일: 2012년 05월

미국의 연조직 재생 시장(2012년)

U.S. Market for Soft Tissue Repair 2012

가격: USD 6,995

출판일: 2012년 05월

미국의 창상 관리 및 조직 관리 시장(2012년)

U.S. Market for Wound and Tissue Management 2012

가격: USD 6,995

출판일: 2012년 02월

메일링 서비스

관심 분야의 최신 보고서 및 컨퍼런스 정보를 이메일로 받아볼 수 있는 서비스 입니다.